BioNTech (NASDAQ: BNTX)
|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of BioNTech (NASDAQ: BNTX) through any online brokerage.
The latest price target for BioNTech (NASDAQ: BNTX) was reported by SVB Leerink on Friday, July 29, 2022. The analyst firm set a price target for 224.00 expecting BNTX to rise to within 12 months (a possible 22.33% upside). 25 analyst firms have reported ratings in the last year.
The stock price for BioNTech (NASDAQ: BNTX) is $183.11 last updated August 5, 2022, 8:00 PM UTC.
There are no upcoming dividends for BioNTech.
BioNTech’s Q3 earnings are confirmed for Tuesday, November 8, 2022.
There is no upcoming split for BioNTech.
BioNTech is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.